GLP1R and Alzheimer disease: Some medications, such as intranasal insulin or GLP-1 analogues, like Ex-4 were shown to ameliorate the symptoms of the disease indicating that insulin signaling can be a potential medicinal target for treatment of AD [10, 15, 43, 44].